Prognostic Markers and the LAS for Lung Transplantation: Impact of New Revisions for Successful Outcome

  • M. Patricia GeorgeEmail author
  • Matthew R. Pipeling


This chapter reviews the history, development, and institution of the lung allocation score (LAS) in the United States. Lung transplantation can be a lifesaving therapy for patients suffering with end-stage lung diseases for which there are no remaining therapeutic options available. Unfortunately, there remains an imbalance between the number of patients in need of this therapy and the availability of suitable donor organs for transplantation. The LAS was developed in the spirit of the important ethical principles in transplantation of utility and justice. More specifically, the objective of the LAS is to decrease waitlist time (and thus risk for waitlist mortality) and to allocate organs based upon medical urgency so as to balance predicted urgency with predicted benefit. The institution of the LAS for the allocation of suitable donor lungs to appropriate candidates on May 4, 2005, literally changed the landscape of lung transplantation overnight. This chapter also explores the ongoing evolution of the LAS as advancements continue to be made in medical therapies and technologies available for the support and management of end-stage lung diseases.


Lung transplantation Lung allocation score LAS Organ allocation Waitlist mortality Transplant benefit Transplant urgency 


  1. 1.
    Cooper JD, Pearson FG, Patterson GA, et al. Technique of successful lung transplantation in humans. J Thorac Cardiovasc Surg. 1987;93(2):173–81.PubMedGoogle Scholar
  2. 2.
    Egan TM, Murray S, Bustami RT, et al. Development of the new lung allocation system in the United States. Am J Transplant. 2006;6(5 Pt 2):1212–27.CrossRefPubMedGoogle Scholar
  3. 3.
    Health Resources and Services Administration, HHS. Organ procurement and transplantation network. Final rule. Fed Regist. 2007;72(46):10616–9.Google Scholar
  4. 4.
    McCurry KR, Shearon TH, Edwards LB, et al. Lung transplantation in the United States, 1998-2007. Am J Transplant. 2009;9(4 Pt 2):942–58.CrossRefPubMedGoogle Scholar
  5. 5.
    Gries CJ, Mulligan MS, Edelman JD, Raghu G, Curtis JR, Goss CH. Lung allocation score for lung transplantation: impact on disease severity and survival. Chest. 2007;132(6):1954–61.CrossRefPubMedGoogle Scholar
  6. 6.
    Osaki S, Maloney JD, Meyer KC, Cornwell RD, Edwards NM, De Oliveira NC. The impact of the lung allocation scoring system at the single national Veterans Affairs Hospital lung transplantation program. Eur J Cardiothorac Surg. 2009;36(3):497–501.CrossRefPubMedGoogle Scholar
  7. 7.
    Kozower BD, Meyers BF, Smith MA, et al. The impact of the lung allocation score on short-term transplantation outcomes: a multicenter study. J Thorac Cardiovasc Surg. 2008;135(1):166–71.PubMedPubMedCentralCrossRefGoogle Scholar
  8. 8.
    Wille KM, Harrington KF, deAndrade JA, Vishin S, Oster RA, Kaslow RA. Disparities in lung transplantation before and after introduction of the lung allocation score. J Heart Lung Transplant. 2013;32(7):684–92.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Egan TM, Edwards LB. Effect of the lung allocation score on lung transplantation in the United States. J Heart Lung Transplant. 2016;35(4):433–9.CrossRefPubMedGoogle Scholar
  10. 10.
    Osho AA, Castleberry AW, Snyder LD, et al. Differential outcomes with early and late repeat transplantation in the era of the lung allocation score. Ann Thorac Surg. 2014;98(6):1914–20, discussion1920–1.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Iribarne A, Russo MJ, Davies RR, et al. Despite decreased wait-list times for lung transplantation, lung allocation scores continue to increase. Chest. 2009;135(4):923–8.CrossRefPubMedGoogle Scholar
  12. 12.
    Liu V, Zamora MR, Dhillon GS, Weill D. Increasing lung allocation scores predict worsened survival among lung transplant recipients. Am J Transplant. 2010;10(4):915–20.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Merlo CA, Weiss ES, Orens JB, et al. Impact of U.S. Lung Allocation Score on survival after lung transplantation. J Heart Lung Transplant. 2009;28(8):769–75.CrossRefPubMedGoogle Scholar
  14. 14.
    Weiss ES, Allen JG, Merlo CA, Conte JV, Shah AS. Lung allocation score predicts survival in lung transplantation patients with pulmonary fibrosis. Ann Thorac Surg. 2009;88(6):1757–64.CrossRefPubMedGoogle Scholar
  15. 15.
    Russo MJ, Iribarne A, Hong KN, et al. High lung allocation score is associated with increased morbidity and mortality following transplantation. Chest. 2010;137(3):651–7.CrossRefPubMedGoogle Scholar
  16. 16.
    Russo MJ, Worku B, Iribarne A, et al. Does lung allocation score maximize survival benefit from lung transplantation? J Thorac Cardiovasc Surg. 2011;141(5):1270–7.CrossRefPubMedGoogle Scholar
  17. 17.
    Maxwell BG, Levitt JE, Goldstein BA, et al. Impact of the lung allocation score on survival beyond 1 year. Am J Transplant. 2014;14(10):2288–94.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Hayanga JWA, Lira A, Aboagye JK, Hayanga HK, D’Cunha J. Extracorporeal membrane oxygenation as a bridge to lung transplantation: what lessons might we learn from volume and expertise? Interact Cardiovasc Thorac Surg. 2016;22(4):406–10.CrossRefPubMedGoogle Scholar
  19. 19.
    Horai T, Shigemura N, Gries C, et al. Lung transplantation for patients with high lung allocation score: single-center experience. Ann Thorac Surg. 2012;93(5):1592–7–discussion1597.CrossRefPubMedGoogle Scholar
  20. 20.
    Shafii AE, Mason DP, Brown CR, et al. Too high for transplantation? Single-center analysis of the lung allocation score. Ann Thorac Surg. 2014;98(5):1730–6.CrossRefPubMedGoogle Scholar
  21. 21.
    Arnaoutakis GJ, Allen JG, Merlo CA, et al. Impact of the lung allocation score on resource utilization after lung transplantation in the United States. J Heart Lung Transplant. 2011;30(1):14–21.CrossRefPubMedGoogle Scholar
  22. 22.
    Maxwell BG, Mooney JJ, Lee P. Increased resource use in lung transplant admissions in the lung allocation score era. Am J Respir Crit Care Med. 2015 Feb 1;191(3):302–8.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Tsuang WM, Vock DM, Copeland C. An acute change in lung allocation score and survival after lung transplantation: a cohort study. Ann Intern Med. 2013;158(9):650–7.CrossRefPubMedGoogle Scholar
  24. 24.
    Schaffer JM, Singh SK, Joyce DL, Reitz BA. Transplantation for idiopathic pulmonary arterial hypertension: improvement in the lung allocation score era. Circulation. 2013;127(25):2503–13.CrossRefPubMedGoogle Scholar
  25. 25.
    Chen H, Shiboski SC, Golden JA, et al. Impact of the lung allocation score on lung transplantation for pulmonary arterial hypertension. Am J Respir Crit Care Med. 2009;180(5):468–74.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Chan KM. Idiopathic pulmonary arterial hypertension and equity of donor lung allocation in the era of the lung allocation score: are we there yet? Am J Respir Crit Care Med. 2009;180(5):385–7.CrossRefPubMedGoogle Scholar
  27. 27.
    Benza RL, Miller DP, Frost A, Barst RJ, Krichman AM, Mcgoon MD. Analysis of the lung allocation score estimation of risk of death in patients with pulmonary arterial hypertension using data from the REVEAL Registry. Transplantation. 2010;90(3):298–305.CrossRefPubMedGoogle Scholar
  28. 28.
    Gomberg-Maitland M, Glassner-Kolmin C, Watson S, et al. Survival in pulmonary arterial hypertension patients awaiting lung transplantation. J Heart Lung Transplant. 2013;32(12):1179–86.CrossRefPubMedGoogle Scholar
  29. 29.
    Allen LA, Felker GM, Pocock S, et al. Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program. Eur J Heart Fail. 2009;11(2):170–7.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Takeda Y, Takeda Y, Tomimoto S, Tani T, Narita H, Kimura G. Bilirubin as a prognostic marker in patients with pulmonary arterial hypertension. BMC Pulm Med. 2010;10:22.CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Russo MJ, Davies RR, Hong KN, et al. Who is the high-risk recipient? Predicting mortality after lung transplantation using pretransplant risk factors. J Thorac Cardiovasc Surg. 2009;138(5):1234–1238.e1.CrossRefPubMedGoogle Scholar
  32. 32.
    Committee OUT. Thoracic Organ Transplatation Committee Meeting Summary [Internet]. 2016;1–3. Available from:
  33. 33.
    Andersen KH, Schultz HHL, Nyholm B, Iversen MP, Gustafsson F, Carlsen J. Pulmonary hypertension as a risk factor for survival after lung transplantation. Clin Transplant. 2016;30(4):357–64.CrossRefPubMedGoogle Scholar
  34. 34.
    Singh VK, Patricia George M, Gries CJ. Pulmonary hypertension is associated with increased post-lung transplant mortality risk in patients with chronic obstructive pulmonary disease. J Heart Lung Transplant. 2015;34(3):424–9.CrossRefPubMedGoogle Scholar
  35. 35.
    Hayes D, Higgins RS, Black SM, et al. Effect of pulmonary hypertension on survival in patients with idiopathic pulmonary fibrosis after lung transplantation: an analysis of the United Network of Organ Sharing registry. J Heart Lung Transplant. 2015;34(3):430–7.CrossRefPubMedGoogle Scholar
  36. 36.
    Hayes D, Higgins RS, Kirkby S, et al. Impact of pulmonary hypertension on survival in patients with cystic fibrosis undergoing lung transplantation: an analysis of the UNOS registry. J Cyst Fibros. 2014;13(4):416–23.CrossRefPubMedGoogle Scholar
  37. 37.
    Singer JP, Blanc PD, Hoopes C, et al. The impact of pretransplant mechanical ventilation on short- and long-term survival after lung transplantation. Am J Transplant. 2011;11(10):2197–204.CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Mason DP, Thuita L, Nowicki ER, Murthy SC, Pettersson GB, Blackstone EH. Should lung transplantation be performed for patients on mechanical respiratory support? The US experience. J Thorac Cardiovasc Surg. 2010;139(3):765–773.e1.CrossRefPubMedGoogle Scholar
  39. 39.
    Gottlieb J, Warnecke G, Hadem J, et al. Outcome of critically ill lung transplant candidates on invasive respiratory support. Intensive Care Med. 2012;38(6):968–75.CrossRefPubMedGoogle Scholar
  40. 40.
    Lang G, Taghavi S, Aigner C, et al. Primary lung transplantation after bridge with extracorporeal membrane oxygenation: a plea for a shift in our paradigms for indications. Transplantation. 2012;93(7):729–36.CrossRefPubMedGoogle Scholar
  41. 41.
    Toyoda Y, Bhama JK, Shigemura N, et al. Efficacy of extracorporeal membrane oxygenation as a bridge to lung transplantation. J Thorac Cardiovasc Surg. 2013;145(4):1065–70, discussion1070–1.CrossRefPubMedGoogle Scholar
  42. 42.
    Hoopes CW, Kukreja J, Golden J, Davenport DL, Diaz-Guzman E, Zwischenberger JB. Extracorporeal membrane oxygenation as a bridge to pulmonary transplantation. J Thorac Cardiovasc Surg. 2013;145(3):862–7, discussion 867–8.CrossRefPubMedGoogle Scholar
  43. 43.
    Hayanga AJ, Aboagye J, Esper S, et al. Extracorporeal membrane oxygenation as a bridge to lung transplantation in the United States: an evolving strategy in the management of rapidly advancing pulmonary disease. J Thorac Cardiovasc Surg. 2015;149(1):291–6.CrossRefPubMedGoogle Scholar
  44. 44.
    Hayes D, Tobias JD, Tumin D. Center volume and extracorporeal membrane oxygenation support at lung transplantation in the Lung Allocation Score Era. Am J Respir Crit Care Med. 2016;194(3):317–26.CrossRefPubMedGoogle Scholar
  45. 45.
    Valapour M, Skeans MA, Smith JM, et al. OPTN/SRTR annual data report 2014: lung. Am J Transplant. 2016;16:141–68.CrossRefPubMedGoogle Scholar
  46. 46.
    Kilic A, Merlo CA, Conte JV, Shah AS. Lung transplantation in patients 70 years old or older: have outcomes changed after implementation of the lung allocation score? J Thorac Cardiovasc Surg. 2012;144(5):1133–8.CrossRefPubMedGoogle Scholar
  47. 47.
    Singer JP, Peterson ER, Snyder ME, et al. Body composition and mortality after adult lung transplantation in the United States. Am J Respir Crit Care Med. 2014;190(9):1012–21.CrossRefPubMedPubMedCentralGoogle Scholar
  48. 48.
    Baldwin MR, Arcasoy SM, Shah A, et al. Hypoalbuminemia and early mortality after lung transplantation: a cohort study. Am J Transplant. 2012;12(5):1256–67.CrossRefPubMedPubMedCentralGoogle Scholar
  49. 49.
    Lederer DJ, Kawut SM, Wickersham N, et al. Obesity and primary graft dysfunction after lung transplantation: the Lung Transplant Outcomes Group Obesity Study. Am J Respir Crit Care Med. 2011;184(9):1055–61.CrossRefPubMedPubMedCentralGoogle Scholar
  50. 50.
    Chandrashekaran S, Keller CA, Kremers WK, Peters SG, Hathcock MA, Kennedy CC. Weight loss prior to lung transplantation is associated with improved survival. J Heart Lung Transplant. 2015;34(5):651–7.CrossRefPubMedGoogle Scholar
  51. 51.
    Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56(3):M146–56.CrossRefGoogle Scholar
  52. 52.
    Singer JP, Diamond JM, Gries CJ, et al. Frailty phenotypes, disability, and outcomes in adult candidates for lung transplantation. Am J Respir Crit Care Med. 2015;192(11):1325–34.CrossRefPubMedPubMedCentralGoogle Scholar
  53. 53.
    Wilson ME, Vakil AP, Kandel P, Undavalli C. Pretransplant frailty is associated with decreased survival after lung transplantation. J Heart Lung Transplant. 2015;35(2):173–8.CrossRefPubMedGoogle Scholar
  54. 54.
    Kelm DJ, Bonnes SL, Jensen MD. Pretransplant wasting (as measured by muscle index) is a novel prognostic indicator in lung transplantation. Clin Transplant. 2016 Mar;30(3):247–55.CrossRefPubMedGoogle Scholar
  55. 55.
    Grimm JC, Valero V, Kilic A, et al. Preoperative performance status impacts perioperative morbidity and mortality after lung transplantation. Ann Thorac Surg. 2015;99(2):482–9.CrossRefPubMedGoogle Scholar
  56. 56.
    Kilic A, Beaty CA, Merlo CA, Conte JV, Shah AS. Functional status is highly predictive of outcomes after redo lung transplantation: an analysis of 390 cases in the modern era. Ann Thorac Surg. 2013;96(5):1804–11, discussion1811.CrossRefPubMedGoogle Scholar

Copyright information

© The Author(s) 2018

Authors and Affiliations

  1. 1.Department of MedicineNational Jewish HealthDenverUSA
  2. 2.Division of Pulmonary, Allergy and Critical Care MedicineUniversity of Pittsburgh School of MedicinePittsburghUSA

Personalised recommendations